Markets
BetterLife Pharma Appoints Charles Duncan to Board: What It Means for BETRF Stock
BetterLife Pharma has added Charles Duncan to its board of directors, a governance move that carries strategic weight for the small-cap psychedelics and cannabinoid drug developer. Here is what the appointment signals — and what traders should watch next.